Phase 2b, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of Intravenous VIS410 in Addition to Oseltamivir (Tamiflu) Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support

Trial Profile

Phase 2b, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of Intravenous VIS410 in Addition to Oseltamivir (Tamiflu) Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Sep 2018

At a glance

  • Drugs VIS 410 (Primary) ; Aspirin; Diphenhydramine; Diphenhydramine; Diphenhydramine; Ibuprofen; Oseltamivir
  • Indications Influenza A virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Visterra
  • Most Recent Events

    • 24 Aug 2018 Planned number of patients changed from 390 to 120.
    • 14 Aug 2018 This trial has been completed in Bulgaria.
    • 28 Jul 2018 This trial has been completed in Spain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top